Liu H, Zhi WW, Liu XZ. Two New Zn(II)/Cd(II) Complexes: Luminescent Properties and Treatment Activity on Cardiovascular Disease.
J Fluoresc 2022;
32:1969-1975. [PMID:
35789317 DOI:
10.1007/s10895-022-02995-2]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Accepted: 06/07/2022] [Indexed: 11/30/2022]
Abstract
Two new supramolecular frameworks, namely [Zn(HBTC)(H2O)2]n·n(MA) (1) and {[Cd(OBDC)2(MA)(H2O)Cl](HMA)3(H2O)10(DMA)}n (2) (H3BTC = 1,3,5-benzenetricarboxylic acid, H2OBDC = phthalic acid, MA = melamine, DMA = N,N'-dimethylacetamide), have been solvothermally prepared. In addition, the solid-state luminescent properties of 1-2 at room temperature was discussed in this article as well. Their application values on the cardiovascular disease treatment were explored and we also discussed the corresponding mechanism simultaneously. Firstly, the IL-6 and IL-18 released into the plasma was measured with indicated ELISA assay. Besides, the real time RT-PCR was also performed, while activation levels of AMPK signaling pathway was determined after compound treatment.
Collapse